针对肠道微生物群作为神经退行性疾病的治疗方法
Tobiloba S Olajide1, Omamuyovwi M Ijomone1,2
1Laboratory for Experimental and Translational Neurobiology, University of Medical Sciences, Ondo, Nigeria.
概括
调节肠道微生物群,特别是益生菌,显示出治疗神经退行性疾病 (NDD) 的前景. 针对肠-大脑轴的干预措施可以提供神经保护并减轻NDD的进展.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群通过微生物群-肠道-大脑轴与大脑进行通信,从而影响恒温.
- 新出现的证据将肠道失调与神经退行性疾病 (NDD) 联系起来.
研究的目的:
- 对NDDs调节肠道微生物群的治疗潜力进行审查.
- 强调益生菌和便微生物群移植 (FMT) 的神经保护作用.
主要方法:
- 审查最近的进展,包括无菌动物模型和FMT.
- 对特定益生菌菌株的研究分析,如 *Lactobacillus* 和 *Bifidobacterium*.
- 检查涉及神经发生,神经递质调节和神经炎症的机制.
主要成果:
- 益生菌通过上调神经营养因子 (如BDNF) 和增强线粒体功能来施加神经保护作用.
- 肠道微生物群的调节影响神经炎症和氧化应激.
- 在针对认知和运动缺陷的临床前和临床研究中,FMT已经取得了成功.
结论:
- 肠道微生物群在NDD中发挥着重要作用.
- 包括益生菌和FMT在内的肠道向干预措施代表了NDD的创新治疗策略.
- 需要进一步的研究才能充分确定FMT在人类中的治疗潜力.
相关概念视频
Microorganisms in Medicine and Therapeutics
360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
205
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
205
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265


